NISA Investment Advisors »

Entrada Therapeutics shares owned by NISA Investment Advisors

Quarter-by-quarter ownership of Entrada Therapeutics (TRDA) shares owned by NISA Investment Advisors from 13F filings

Historical chart of NISA Investment Advisors investment in Entrada Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Entrada Therapeutics held by NISA Investment Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Entrada Therapeutics by NISA Investment Advisors

Quarter filed Position value Share count Share price at filing
2023-12-31 $151 10 15.10
2022-03-31 $7.0k 700 10.00

More positions owned by NISA Investment Advisors

Apple XXX (AAPL)
Microsoft Corp XXX (MSFT)
Nvidia Corp XXX (NVDA)
Amazon.com XXX (AMZN)
Alphabet Inc-cl A XXX (GOOGL)
Alphabet Inc-cl C XXX (GOOG)
Ishares 20year Treasury Bond XXX (TLT)
Meta Platforms Inc-a XXX (META)
Jp Morgan Chase & Co XXX (JPM)
Unitedhealth Group XXX (UNH)
Tesla XXX (TSLA)
Eli Lilly & Co XXX (LLY)
Visa Inc - Class A Shares XXX (V)
Mastercard XXX (MA)
Broadcom XXX (AVGO)

View all positions for NISA Investment Advisors

Top funds holding Entrada Therapeutics

Baker Bros. Advisors
5AM Venture Management
T. Rowe Price Associates
Redmile Group
Vanguard Group
Wellington Management Company
72 Investment Holdings
Charles Schwab Investment Management
TD Asset Management
Bank of New York Mellon
Moore Capital Management
Barclays
Corton Capital
Rhumbline Advisers
Bank of America Corporation

View all funds holding Entrada Therapeutics